In patients with renal impairment, rocuronium and sugammadex are the primary choice for reversing neuromuscular blockade, ...

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...

Food - Allergen - Peanut Distribution:       Alberta                           Newfoundland and Labrador                           Ontario See the affected products and product photos for this ...

Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...

Glycosuria indicates a serum glucose level above the renal threshold for reabsorption (excess of 11.6 mmol/l). Screening for glycosuria remains a part of standard prenatal care, although the ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

An 'aging population' and reduction in available beds could create a 'hospital bed shortage' within the next 10 years, ...

Intra-Cellular Therapies, Inc. Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in 2023. Full year 2024 CAPLY ...

In both studies, the primary endpoint was met as the neutralizing antibody titers exceeded the threshold agreed with regulatory authorities as a marker of seroprotection. The most common adverse ...

Endosomal recycling is a branch of intracellular membrane trafficking that retrieves endocytosed cargo proteins from early and late endosomes to prevent their degradatio ...